Treatment with ODZ10117 effectively suppressed the tyrosine phosphorylation and nuclear translocation of STAT3, resulting in the effective inhibition of migration, invasion, stem cell properties, and MES signatures in glioblastoma cells and GSCs. The gene discussed is STAT3; the disease is glioblastoma.